Clinico-immunologic changes in patients with cervical cancer after treatment with thymalin

The results of a clinical study of a polypeptide preparation of the thymus-thymalin in 50 patients with cervical carcinoma are discussed. Thymalin was found to exert a beneficial effect in various immuno-suppressive states involved in carcinoma of uterine cervix. Since the preparation has a distinct...

Full description

Saved in:
Bibliographic Details
Published inVoprosy onkologij Vol. 30; no. 3; p. 29
Main Authors Dekster, L I, Nikolaeva, L Ia, Bokhman, Ia V, Letskiĭ, V B, Morozov, V G
Format Journal Article
LanguageRussian
Published Russia (Federation) 1984
Subjects
Adjuvants, Immunologic - administration & dosage
Antibody Formation
B-Lymphocytes - immunology
Female
Humans
Immunity, Cellular
T-Lymphocytes - immunology
Thymus Hormones - administration & dosage
Time Factors
Uterine Cervical Neoplasms - immunology
Uterine Cervical Neoplasms - therapy
Online AccessGet more information

Cover

More Information
Summary:The results of a clinical study of a polypeptide preparation of the thymus-thymalin in 50 patients with cervical carcinoma are discussed. Thymalin was found to exert a beneficial effect in various immuno-suppressive states involved in carcinoma of uterine cervix. Since the preparation has a distinct stimulating effect, its administration should be included into different schemes of complex therapy of cervical carcinoma.
ISSN:0507-3758